PetIQ Inc (NASDAQ:PETQ) – Investment analysts at William Blair increased their FY2018 earnings per share (EPS) estimates for PetIQ in a research report issued to clients and investors on Tuesday, Zacks Investment Research reports. William Blair analyst J. Andersen now anticipates that the company will earn $0.87 per share for the year, up from their prior estimate of $0.82.
PetIQ (NASDAQ:PETQ) last released its earnings results on Monday, November 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.14 by $0.15.
Several other equities research analysts have also commented on the company. Jefferies Group reissued a “buy” rating and set a $27.00 price target on shares of PetIQ in a research note on Monday, January 8th. Zacks Investment Research lowered PetIQ from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 12th. Finally, BidaskClub raised PetIQ from a “hold” rating to a “buy” rating in a research note on Tuesday, January 23rd. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $26.83.
Shares of PetIQ (NASDAQ PETQ) opened at $22.70 on Thursday. The company has a market capitalization of $479.19 and a P/E ratio of -84.07. The company has a debt-to-equity ratio of 0.19, a quick ratio of 4.67 and a current ratio of 6.83. PetIQ has a 52 week low of $17.03 and a 52 week high of $28.23.
A number of large investors have recently bought and sold shares of PETQ. American International Group Inc. purchased a new position in PetIQ in the 3rd quarter valued at about $131,000. Wells Fargo & Company MN purchased a new position in PetIQ in the 3rd quarter valued at about $204,000. California State Teachers Retirement System purchased a new position in PetIQ in the 3rd quarter valued at about $320,000. Schwab Charles Investment Management Inc. purchased a new position in PetIQ in the 3rd quarter valued at about $344,000. Finally, New York State Common Retirement Fund purchased a new position in PetIQ in the 3rd quarter valued at about $448,000. 57.54% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION WARNING: This news story was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/02/04/fy2018-eps-estimates-for-petiq-inc-petq-raised-by-william-blair.html.
PetIQ, Inc is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield.
Get a free copy of the Zacks research report on PetIQ (PETQ)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.